{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:53:49Z","timestamp":1784235229580,"version":"3.55.0"},"reference-count":59,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Health and Biological Sciences, Abasyn University Peshawar"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The swift emergence of antibiotic resistance (AR) in bacterial pathogens to make themselves adaptable to changing environments has become an alarming health issue. To prevent AR infection, many ways can be accomplished such as by decreasing the misuse of antibiotics in human and animal medicine. Among these AR bacterial species, Plesiomonas shigelloides is one of the etiological agents of intestinal infection in humans. It is a gram-negative rod-shaped bacterium that is highly resistant to several classes of antibiotics, and no licensed vaccine against the aforementioned pathogen is available. Hence, substantial efforts are required to screen protective antigens from the pathogen whole genome that can be subjected easily to experimental evaluations. Here, we employed a reverse vaccinology (RV) approach to design a multi-antigenic epitopes based vaccine against P. shigelloides. The complete genomes of P. shigelloides were retrieved from the National Center for Biotechnological Information (NCBI) that on average consist of 5226 proteins. The complete proteomes were subjected to different subtractive proteomics filters, and in the results of that analysis, out of total proteins, 2399 were revealed as non-redundant and 2827 as redundant proteins. The non-redundant proteins were further checked for subcellular localization analysis, in which three were localized in the extracellular matrix, eight were outer membrane, and 13 were found in the periplasmic membrane. All surface localized proteins were found to be virulent. Out of a total of 24 virulent proteins, three proteins (flagellar hook protein (FlgE), hypothetical protein, and TonB-dependent hemoglobin\/transferrin\/lactoferrin family receptor protein) were considered as potential vaccine targets and subjected to epitopes prediction. The predicted epitopes were further examined for antigenicity, toxicity, and solubility. A total of 10 epitopes were selected (GFKESRAEF, VQVPTEAGQ, KINENGVVV, ENKALSQET, QGYASANDE, RLNPTDSRW, TLDYRLNPT, RVTKKQSDK, GEREGKNRP, RDKKTNQPL). The selected epitopes were linked with each other via specific GPGPG linkers in order to design a multi-epitopes vaccine construct, and linked with cholera toxin B subunit adjuvant to make the designed vaccine construct more efficient in terms of antigenicity. The 3D structure of the vaccine construct was modeled ab initio as no appropriate template was available. Furthermore, molecular docking was carried out to check the interaction affinity of the designed vaccine with major histocompatibility complex (MHC-)I (PDB ID: 1L1Y), MHC-II (1KG0), and toll-like receptor 4 ((TLR-4) (PDB: 4G8A). Molecular dynamic simulation was applied to evaluate the dynamic behavior of vaccine-receptor complexes. Lastly, the binding free energies of the vaccine with receptors were estimated by using MMPB\/GBSA methods. All of the aforementioned analyses concluded that the designed vaccine molecule as a good candidate to be used in experimental studies to disclose its immune protective efficacy in animal models.<\/jats:p>","DOI":"10.3390\/vaccines10111886","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T02:44:32Z","timestamp":1667961872000},"page":"1886","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Computational Design of a Chimeric Vaccine against Plesiomonas shigelloides Using Pan-Genome and Reverse Vaccinology"],"prefix":"10.3390","volume":"10","author":[{"given":"Mahnoor","family":"Mushtaq","sequence":"first","affiliation":[{"name":"Department of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifullah","family":"Khan","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology and Microbiology, Bacha Khan University, Charsadda 24461, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Bacha Khan University, Charsadda 24461, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-2886","authenticated-orcid":false,"given":"Alhanouf","family":"Al-Harbi","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, College of Applied Medical Sciences, Taibah University, Yanbu 46411, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Hameed","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Techniques, School of Life Sciences, Dijlah University College, Baghdad 59058, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadeeja","family":"Khan","sequence":"additional","affiliation":[{"name":"Lahore General Hospital, Lahore 54000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8793-2972","authenticated-orcid":false,"given":"Saba","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, National University of Medical Sciences, Rawalpindi 46000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Irfan","sequence":"additional","affiliation":[{"name":"Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, FL 32611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Health and Biological Sciences, Abasyn University, Peshawar 25000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tifs.2018.08.001","article-title":"Antibiotic resistance in foodborne bacteria","volume":"84","author":"Manageiro","year":"2019","journal-title":"Trends Food Sci. Technol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1126\/science.aax3879","article-title":"The evolution of antibiotic resistance","volume":"365","author":"MacLean","year":"2019","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2014.10.027","article-title":"Therapeutic strategies to combat antibiotic resistance","volume":"78","author":"Brooks","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_4","unstructured":"PCAST (2015). National Action Plan for Combatting Antibiotic-Resistant Bacteria, White House."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molcel.2014.03.010","article-title":"Bacteria fighting back: How pathogens target and subvert the host innate immune system","volume":"54","author":"Reddick","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14760584.2018.1470507","article-title":"Vaccines for healthcare-associated infections: Present, future, and expectations","volume":"17","author":"Lucht","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: A qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3389\/fimmu.2018.02315","article-title":"Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges","volume":"9","author":"Bidmos","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1586\/erv.09.67","article-title":"Next-generation sequencing: A transformative tool for vaccinology","volume":"8","author":"Dhiman","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fimmu.2019.00113","article-title":"Comparison of open-source Reverse Vaccinology programs for bacterial vaccine antigen discovery","volume":"10","author":"Dalsass","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combatting antimicrobial resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.4.3.6313","article-title":"Genome-based vaccine development: A short cut for the future","volume":"4","author":"Moriel","year":"2008","journal-title":"Hum. Vaccin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"104551","DOI":"10.1016\/j.meegid.2020.104551","article-title":"Subtractive proteomics and immunoinformatics approaches to explore Bartonella bacilliformis proteome (virulence factors) to design B and T cell multi-epitope subunit vaccine","volume":"85","author":"Gul","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1038\/s41598-022-12651-1","article-title":"In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches","volume":"12","author":"Omoniyi","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/CMR.00103-15","article-title":"Plesiomonas shigelloides revisited","volume":"29","author":"Janda","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_16","unstructured":"Kelly, D.F., and Rappuoli, R. (2005). Hot Topics in Infection and Immunity in Children II, Springer."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Selim, S., Almuhayawi, M.S., Zakai, S.A., Salama, A.A., and Warrad, M. (2022). Distinction between Antimicrobial Resistance and Putative Virulence Genes Characterization in Plesiomonas shigelloides Isolated from Different Sources. Antibiotics, 11.","DOI":"10.3390\/antibiotics11010085"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/iai.61.9.3678-3687.1993","article-title":"Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids","volume":"61","author":"Taylor","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1080\/21645515.2019.1606972","article-title":"Classical and novel strategies to develop a Shigella glycoconjugate vaccine: From concept to efficacy in human","volume":"15","author":"Barel","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Herrera, C.M., Schmitt, J.S., Chowdhry, E.I., and Riddle, M.S. (2022). From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review. Vaccines, 10.","DOI":"10.3390\/vaccines10050645"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1021\/jacs.8b00148","article-title":"Total synthesis of a densely functionalized Plesiomonas shigelloides serotype 51 aminoglycoside trisaccharide antigen","volume":"140","author":"Qin","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ygeno.2017.05.001","article-title":"Prediction of vaccine candidates against Pseudomonas aeruginosa: An integrated genomics and proteomics approach","volume":"109","author":"Rashid","year":"2017","journal-title":"Genomics"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hassan, A., Naz, A., Obaid, A., Paracha, R.Z., Naz, K., Awan, F.M., Muhmmad, S.A., Janjua, H.A., Ahmad, J., and Ali, A. (2016). Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets. BMC Genom., 17.","DOI":"10.1186\/s12864-016-2951-4"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.genrep.2017.04.008","article-title":"Identification of plausible drug targets by investigating the druggable genome of MDR Staphylococcus epidermidis","volume":"7","author":"Sanober","year":"2017","journal-title":"Gene Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"190907","DOI":"10.1098\/rsos.190907","article-title":"Reverse vaccinology and subtractive genomics reveal new therapeutic targets against Mycoplasma pneumoniae: A causative agent of pneumonia","volume":"6","author":"Jaiswal","year":"2019","journal-title":"R. Soc. Open Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biologicals.2017.08.004","article-title":"Towards a peptide-based vaccine against Shigella sonnei: A subtractive reverse vaccinology based approach","volume":"50","author":"Baseer","year":"2017","journal-title":"Biologicals"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.meegid.2011.10.017","article-title":"Mycoplasma genitalium: A comparative genomics study of metabolic pathways for the identification of drug and vaccine targets","volume":"12","author":"Butt","year":"2012","journal-title":"Infect. Genet. Evol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/bioinformatics\/btl158","article-title":"Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences","volume":"22","author":"Li","year":"2006","journal-title":"Bioinformatics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"572642","DOI":"10.3389\/fmicb.2020.572642","article-title":"Comparative Genomic Analysis Reveals Genetic Mechanisms of the Variety of Pathogenicity, Antibiotic Resistance, and Environmental Adaptation of Providencia Genus","volume":"11","author":"Yuan","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.meegid.2015.03.027","article-title":"Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: A reverse vaccinology based approach","volume":"32","author":"Naz","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00335-003-2296-6","article-title":"Secreted protein prediction system combining CJ-SPHMM, TMHMM, and PSORT","volume":"14","author":"Chen","year":"2003","journal-title":"Mamm. Genome"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jmgm.2018.01.010","article-title":"Immuno-informatics driven proteome-wide investigation revealed novel peptide-based vaccine targets against emerging multiple drug resistant Providencia stuartii","volume":"80","author":"Asad","year":"2018","journal-title":"J. Mol. Graph. Model."},{"key":"ref_33","unstructured":"Gasteiger, E., Hoogland, C., Gattiker, A., Wilkins, M.R., Appel, R.D., and Bairoch, A. (2005). The Proteomics Protocols Handbook, Springer."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes","volume":"305","author":"Krogh","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/bioinformatics\/17.9.849","article-title":"The HMMTOP transmembrane topology prediction server","volume":"17","author":"Tusnady","year":"2001","journal-title":"Bioinformatics"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Doytchinova, I.A., and Flower, D.R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform., 8.","DOI":"10.1186\/1471-2105-8-4"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.6026\/97320630012074","article-title":"MFPPI\u2013multi FASTA ProtParam interface","volume":"12","author":"Garg","year":"2016","journal-title":"Bioinformation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.meegid.2017.04.009","article-title":"Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches","volume":"51","author":"Saadi","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: Protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1241934","article-title":"Causes and effects of N-terminal codon bias in bacterial genes","volume":"342","author":"Goodman","year":"2013","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1107\/S0907444998009378","article-title":"Protein Data Bank (PDB): Database of three-dimensional structural information of biological macromolecules","volume":"54","author":"Sussman","year":"1998","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gki481","article-title":"PatchDock and SymmDock: Servers for rigid and symmetric docking","volume":"33","author":"Inbar","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/prot.21495","article-title":"FireDock: Fast interaction refinement in molecular docking","volume":"69","author":"Andrusier","year":"2007","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/lam.13237","article-title":"Genomic analysis of two drug-resistant clinical Morganella morganii strains isolated from UTI patients in Pretoria, South Africa","volume":"70","author":"Mbelle","year":"2020","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/JB.00067-10","article-title":"Complete genome sequence of Enterobacter cloacae subsp. cloacae type strain ATCC 13047","volume":"192","author":"Ren","year":"2010","journal-title":"J. Bacteriol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1021\/acs.jcim.0c00613","article-title":"Alchemical binding free energy calculations in AMBER20: Advances and best practices for drug discovery","volume":"60","author":"Lee","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rapin, N., Lund, O., Bernaschi, M., and Castiglione, F. (2010). Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009862"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","article-title":"PSORTb 3.0: Improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes","volume":"26","author":"Yu","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.3389\/fmicb.2018.03077","article-title":"Pathogenomics of virulence traits of Plesiomonas shigelloides that were deemed inconclusive by traditional experimental approaches","volume":"9","author":"Ekundayo","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3389\/fimmu.2019.01722","article-title":"Vaccine evolution and its application to fight modern threats","volume":"10","author":"Andreano","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/jcc.25187","article-title":"Fast and flexible gpu accelerated binding free energy calculations within the amber molecular dynamics package","volume":"39","author":"Mermelstein","year":"2018","journal-title":"Comput. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"W502","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: Immune epitope database\u2014Analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.meegid.2016.03.036","article-title":"Phylogenetic analysis of a newfound bat-borne hantavirus supports a laurasiatherian host association for ancestral mammalian hantaviruses","volume":"41","author":"Witkowski","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"ref_57","unstructured":"Yero, D., Conchillo-Sol\u00e9, O., and Daura, X. (2021). Vaccine Delivery Technology, Springer."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.11648\/j.cbb.20140201.13","article-title":"Computational design of peptide vaccine against Acinetobacter baumannii infection using comparative genomic approach","volume":"2","author":"Taiwo","year":"2014","journal-title":"Comput. Biol. Bioinform."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/1570164617999200505095802","article-title":"Prediction of Prophylactic Peptide Vaccine Candidates for Human Papillomavirus (HPV): Immunoinformatics and Reverse Vaccinology Approaches","volume":"18","author":"Ismail","year":"2021","journal-title":"Curr. Proteom."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/11\/1886\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:12:42Z","timestamp":1760145162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/11\/1886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["vaccines10111886"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10111886","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]}}}